Composition influence on pulmonary delivery of rifampicin liposomes

Pharmaceutics

Volumn 4, Issue 4, 2012, Pages 590-606

  Manca, Maria Letizia ^a   Sinico, Chiara ^a   Maccioni, Anna Maria ^a   Diez, Octavio ^b   Fadda, Anna Maria ^a   Manconi, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aerosol; Cell viability; Cellular uptake; Cholesterol; Liposomes; Oleic acid; Pulmonary delivery; Rheology; Rifampicin

Indexed keywords

LIPOSOME; OLEIC ACID; PHOSPHATIDYLCHOLINE; RIFAMPICIN;

ARTICLE; CELL INTERACTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG FORMULATION; ENCAPSULATION; FLOW KINETICS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LIPID ANALYSIS; LIPID COMPOSITION; LIPOSOMAL DELIVERY; PHYSICAL CHEMISTRY; TEMPERATURE SENSITIVITY; TRANSITION TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84871551447     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics4040590     Document Type: Article

References (39)

1. Mura, C.; Nácher, A.; Merino, V.; Merino-Sanjuan, M.; Carda, C.; Ruiz, A.; Manconi, M.; Diez-Sales, O. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in rats. Int. J. Pharm. 2011, 416, 145-154.
2. Delmas, T.; Fraichard, A.; Bayle, P.A.; Texier, I.; Bardet, M.; Baudry, J.; Bibette, J.; Couffin, A.C. Encapsulation and release behavior from lipid nanoparticles: Model study with nile red fluorophore. J. Colloid Sci. Biotechnol. 2012, 1, 16-25.
3. Gonnet, M.; Bastiat, G.; Ivanova, T.; Boury, F. Interfacial organization of Β-carotene loaded lipid nanocapsules modelized by 2D rheological measurements and electrophoretic mobility. J. Colloid Sci. Biotechnol. 2012, 1, 137-146.
4. Manca, M.L.; Mourtas, S.; Drakopoulos, V.; Fadda, A.M.; Antimisiaris, S. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Coll. Surf. B Biointerf. 2008, 62, 220-131.
5. Zaru, M.; Manca, M.L.; Fadda, A.M.; Antimisiaris, S. Chitosan-coated liposomes for delivery to lungs by nebulisation. Coll. Surf. B Biointerf. 2009, 71, 88-95.
6. Marianecci, C.; Paolino, P.; Celia, C.; Fresta, M.; Carafa, M.; Alhaique, F. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts. J. Contr. Release 2010, 147, 127-135.
7. Mura, S.; Hillaireau, H.; Nicolas, J.; Kerdine-Römer, S.; Le Droumaguet, B.; Deloménie, C.; Nicolas, V.; Pallardy, M.; Tsapis, N.; Fattal, E. Biodegradable Nanoparticles Meet the Bronchial Airway Barrier: How Surface Properties Affect Their Interaction with Mucus and Epithelial Cells. Biomacromolecules 2011, 12, 4136-4143.
8. Cassano, R.; Trombino, S.; Ferrarelli, T.; Mauro, M.V.; Giraldi, C.; Manconi, M.; Fadda, A.M.; Picci, N. Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment. J. Biomed. Mater. Res. Part A 2012, 2, 536-542.
9. Ungaro, F.; d'Angelo, I.; Miro, A.; La Rotonda, M.I.; Quaglia, F. Engineered PLGA nano and micro-carriers for pulmonary delivery: Challenges and promises. J. Pharm. Pharmacol. 2012, 64, 1217-1235.
10. Pinheiro, M.; Lúcio, M.; Lima, J.L.F.C.; Reis, S. Liposomes as drug delivery systems for the treatment of TB. Nanomedicine 2011, 6, 1413-1428.
11. Kurmi, B.D.; Kayat, J.; Gajbhiye, V.; Tekade, R.K.; JainKurmi, N.K. Microand nanocarrier-mediated lung targeting. Expert Opin. Drug Deliv. 2012, 7, 781-794.
12. Traini, D.; Young, P.M. Delivery of antibiotics to therespiratory tract: an update. Expert Opin. Drug Deliv. 2009, 6, 897-905.
13. Jaafar-Maalej, C.; Andrieu, V.; Elaissari, A.; Fessi, H. Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: Preparation, characterization and in vitro drug release. J. Nanosci. Nanotechnol. 2011, 11, 1841-1851.
14. Jaafar-Maalej, C.; Elaissari, A.; Fessi, H. Lipid-based carriers: Manufacturing and applications for pulmonary route. Expert Opin. Drug Deliv. 2012, 9, 1111-1127.
15. Geiser, M.; Cruz-Orive, L.M.; Im Hof, V.; Gehr, P. Assessment of particle retention and clearance in the intrapulmonary conducting airways of hamster lungs with the fractionator. J. Microsc. 1990, 160, 75-88.
16. Geiser, M.; Baumann, M.; Cruz-Orive, L.M.; Im Hof, V.; Waber, U.; Gehr, P. The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters. Am. J. Respir. Cell Mol. Biol. 1994, 10, 594-603.
17. Verma, R.K.; Singh, A.K.; Mohan, M.; Agrawal, A.K.; Misra, A. Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug delivery systems. Therapeutic Delivery 2011, 2, 753-768.
18. Poletto, F.S.; Fiel, L.A.; Lopes, M.V.; Schaab, G.; Gomes, A.M.O.; Guterres, S.S.; Rossi-Bergmann, B.; Pohlmann, A.R. Fluorescent-Labeled Poly (E-caprolactone) Lipid-Core Nanocapsules: Synthesis, Physicochemical Properties and Macrophage Uptake. J. Colloid Sci. Biotechnol. 2012, 1, 89-98.
19. Vyas, S.P.; Kannan, M.E.; Jain, S.; Mishra, V.; Singh, P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 2004, 269, 37-49.
20. Chono, S.; Tanino, T.; Seki, T.; Morimoto, K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J. Contr. Release 2008, 127, 50-58.
21. Zaru, M.; Mourtas, S.; Klepetsanis, P.; Fadda, A.M.; Antimisiaris, S.G. Liposomes for drug delivery to the lungs by nebulization. Eur. J. Pharm. Biopharm. 2007, 67, 655-666.
22. Zaru, M.; Sinico, C.; De Logu, A.; Caddeo, C.; Lai, F.; Manca, M.L.; Fadda, A.M. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: In vitro and in vivo evaluation. J. Lip. Res. 2009, 71, 88-95.
23. Manca, M.L.; Manconi, M.; Valenti, D.; Lai, F.; Loy, G.; Matricardi, P.; Fadda, A.M. Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin. J. Pharm. Sci. 2012, 101, 566-575.
24. Coderch, L.; Fonollosa, J.; de Pera, M.; Estelrich, J.; de La Maza, A.; Parra, J.L. Influence of cholesterol on liposome fluidity by EPR: Relationship with percutaneous absorption. J. Control. Release 2000, 68, 85-95.
25. Calvagno, M.G.; Celia, C.; Paolino, P.; Cosco, D.; Iannone, M.; Castelli, F.; Doldo, P.; Fresta, M. Effects of Lipid Composition and Preparation Conditions on Physical-Chemical Properties, Technological Parameters and In Vitro Biological Activity of Gemcitabine-Loaded Liposomes. Curr. Drug Deliv. 2007, 4, 89-101.
26. Revilla, J.; Elaissari, A.; Carriere, P.; Pichot, C. Adsorption of Bovine Serum Albumin onto Polystyrene Latex Particles Bearing Saccharidic Moieties. J. Colloid Interf. Sci. 1996, 180, 405-412.
27. Manconi, M.; Sinico, C.; Caddeo, C.; Vila, A.O.; Valenti, D.; Fadda, A.M. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int. J. Pharm. 2011, 412, 37-46.
28. Manconi, M.; Caddeo, C.; Sinico, C.; Valenti, D.; Mostallino, M.C.; Biggio, G.; Fadda, A.M. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. Eur. J. Pharm. Biopharm. 2011, 78, 27-35.
29. Chessa, M.; Caddeo, C.; Valenti, D.; Manconi, M.; Sinico, C.; Fadda, A.M. Effect of Penetration Enhancer Containing Vesicles on the Percutaneous Delivery of Quercetin through New Born Pig Skin. Pharmaceutics 2011, 3, 497-509.
30. Gradzielski, M. The rheology of vesicle and disk systems. Relations between macroscopic behaviour and microstructure. Curr. Opin. Colloid. Interface Sci. 2011, 16, 13-17.
31. Gaspar, M.M.; Bakowsky, U.; Ehrhardt, C. Inhaled liposomes-Current strategies and future challenges. J. Biomed. Nanotechnol. 2008, 4, 1-13.
32. Bridges, P.A.; Taylor, K. An investigation of some of the factors influencing the jet nebulisation of liposomes. Int. J. Pharm. 2000, 204, 69-79.
33. Taylor, K.M.G.; Taylor, G.; Kellaway, I.W.; Stevens, J. The stability of liposomes to nebulisation. Int. J. Pharm. 1990, 58, 57-61.
34. Pilane, C.M.; Labelle, E.F. cPLA2 activator peptide, PLAP, increases arachidonic acid release and apoptosis of vascular smooth muscle cells. J. Cell. Physiol. 2004, 198, 48-52.
35. Ulloth, J.E.; Casiano, C.A.; de Leon, M. Palmitic and stearic fatty acids induce caspase-dependent and-independent cell death in nerve growth factor differentiated PC12 cells. J. Neurochem. 2003, 84, 655-668.
36. Beeharry, N.; Chambers, J.A.; Green, I.C. Fatty acid protection from palmitic acid-induced apoptosis is lost following PI3-kinase inhibition. Apoptosis 2004, 9, 599-607.
37. Avivi-Green, C.; Polak-Charcon, S.; Madar, Z.; Schwartz, B. Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J. Nutr. 2002, 132, 1812-1818.
38. Lee, R.J.; Wang, S.; Turk, M.J.; Low, P.S. The Effects of pH and Intraliposomal Buffer Strength on the Rate of Liposome Content Release and Intracellular Drug Delivery. Biosci. Rep. 1998, 18, 69-78.
39. Manconi, M.; Isola, R.; Falchi, A.M.; Sinico, C.; Fadda, A.M. Intracellular distribution of fluorescent probes delivered by vesicles of different lipidic composition. Coll. Surf. B Biointerface 2007, 57, 143-151.